Skip to main content

Table 2 Average service utilization classified by type of services, patient characteristics, and hospitals

From: Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children

 

Outpatient

Hospitalization

Average length of stay

(days, SD)

Blood

 

Category

service (visits, SD)

(%)

Per all patients

Per hospitalized patients

transfusion (times, SD)

Desferrioxamine

(vials, SD)

Hospital

      

   Saraburi (N = 72)

6.74 (3.31)

15 (20.8%)

0.68 (1.76)

3.27 (2.58)

3.69 (3.59)

3.43 (20.42)

Phramongkutklao

(N = 42)

9.76 (4.44)

-

-

-

8.64 (5.74)

93.95 (105.41)

   Chulalongkorn (N = 87)

11.05 (4.37)

7 (8.0%)

0.69 (3.48)

8.57 (9.74)

9.86 (5.44)

53.77 (82.50)

Disease type

      

   Beta-thal/Hb E (N = 183)

8.86 (4.31)

20 (10.9%)

0.57 (2.64)

5.25 (6.39)

6.94 (5.57)

39.59 (79.17)

Homozygous beta-thal

(N = 18)

13.06 (4.30)

2 (11.1%)

0.22 (0.73)

2.00 (1.41)

12.06 (4.32)

90.33 (83.78)

Severity

      

   Severe (N = 94)

10.41 (4.14)

16 (17.0%)

0.95 (3.53)

5.56 (7.07)

9.35 (4.93)

58.63 (89.75)

   Nonsevere (N = 106)

8.26 (4.46)

6 (5.7%)

0.19 (0.92)

3.33 (2.25)

5.74 (5.72)

31.70 (70.03)

Ferritin level

      

   ≤ 2,500 ng/ml (N = 77)

10.60 (3.51)

5 (6.5%)

0.17 (0.80)

2.60 (2.07)

8.96 (4.55)

51.38 (88.92)

   > 2,500 ng/ml (N = 50)

11.76 (3.91)

5 (10.0%)

1.20 (4.60)

12.00 (9.82)

11.24 (4.94)

96.02 (92.76)

Complications

      

   Yes (N = 18)

11.83 (3.92)

3 (16.7%)

0.56 (1.54)

3.33 (2.52)

10.39 (4.84)

113.44 (123.39)

   No (N = 183)

8.98 (4.44)

19 (10.4%)

0.54 (2.61)

5.21 (6.56)

7.10 (5.65)

37.32 (72.18)

Total

201

22 (10.9%)

201

22

201

201

   Mean

9.23

n/a

0.54

4.95

7.40

44.13

   Standard deviation (SD)

4.46

n/a

2.53

6.16

5.65

80.69

   Median

9.00

n/a

0.00

3.00

8.00

0.00

   95% CI

      

Lower

8.61

n/a

0.19

2.22

6.61

32.91

Upper

9.85

n/a

0.89

7.69

8.18

55.36